The efficacy of ribavirin in Crimean-Congo hemorrhagic fever-randomized trials are urgently needed

Basit Öğe Kaydı
dc.authorid0000-0001-9658-7560
dc.contributor.authorCeylan, Bahadır
dc.contributor.authorTurhan, Vedat
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:56:42Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:56:42Z
dc.date.issued2014
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalı
dc.descriptionWOS: 000348023600065
dc.descriptionPubMed ID: 25461235
dc.description.abstractThe only antiviral drug used today in Crimean-Congo hemorrhagic fever (CCHF) is ribavirin; however, its efficacy is controversial due to the lack of randomized controlled trials. The studies examining the efficacy of ribavirin in CCHF have generally been retrospective studies including insufficient numbers of patients, resulting in low power. We think that ribavirin should not be used in CCHF until randomized controlled studies have been conducted, and that only supportive treatment should be used.
dc.identifier.citationCeylan, B. ve Turhan, V. (2014). The efficacy of ribavirin in Crimean-Congo hemorrhagic fever-randomized trials are urgently needed. International Journal of Infectious Diseases, 29, 297-298. https://dx.doi.org/10.1016/j.ijid.2014.08.015
dc.identifier.doi10.1016/j.ijid.2014.08.015
dc.identifier.endpage298
dc.identifier.issn1201-9712
dc.identifier.issn1878-3511
dc.identifier.scopusqualityQ1
dc.identifier.startpage297
dc.identifier.urihttps://dx.doi.org/10.1016/j.ijid.2014.08.015
dc.identifier.urihttps://hdl.handle.net/20.500.12511/2790
dc.identifier.volume29
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofInternational Journal of Infectious Diseasesen_US
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCrimean-Congo
dc.subjectHemorrhagic Fever-Randomized Trials
dc.titleThe efficacy of ribavirin in Crimean-Congo hemorrhagic fever-randomized trials are urgently needed
dc.typeLetter

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Ceylan, Bahadir-2014.pdf
Boyut:
246.55 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Diğer Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu